308 related articles for article (PubMed ID: 27392869)
1. Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function.
Leighton PL; Allison WT
J Alzheimers Dis; 2016 Jul; 54(1):3-29. PubMed ID: 27392869
[TBL] [Abstract][Full Text] [Related]
2. Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.
Allison WT; DuVal MG; Nguyen-Phuoc K; Leighton PLA
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064456
[TBL] [Abstract][Full Text] [Related]
3. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
Marrero-Winkens C; Sankaran C; Schätzl HM
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
[TBL] [Abstract][Full Text] [Related]
4. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
5. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
[TBL] [Abstract][Full Text] [Related]
6. Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.
Cortez LM; Campeau J; Norman G; Kalayil M; Van der Merwe J; McKenzie D; Sim VL
J Virol; 2015 Aug; 89(15):7660-72. PubMed ID: 25972546
[TBL] [Abstract][Full Text] [Related]
7. The P's and Q's of cellular PrP-Aβ interactions.
Westaway D; Jhamandas JH
Prion; 2012; 6(4):359-63. PubMed ID: 22874673
[TBL] [Abstract][Full Text] [Related]
8. Games played by rogue proteins in prion disorders and Alzheimer's disease.
Aguzzi A; Haass C
Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
[TBL] [Abstract][Full Text] [Related]
9. Developing therapeutics for the diseases of protein misfolding.
May BC; Govaerts C; Cohen FE
Neurology; 2006 Jan; 66(2 Suppl 1):S118-22. PubMed ID: 16432139
[TBL] [Abstract][Full Text] [Related]
10. From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis.
Grad LI; Fernando SM; Cashman NR
Neurobiol Dis; 2015 May; 77():257-65. PubMed ID: 25701498
[TBL] [Abstract][Full Text] [Related]
11. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
Eraña H; Venegas V; Moreno J; Castilla J
Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581
[TBL] [Abstract][Full Text] [Related]
12. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
13. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?
Ludolph AC; Brettschneider J
Eur J Neurol; 2015 May; 22(5):753-61. PubMed ID: 25846565
[TBL] [Abstract][Full Text] [Related]
17. Engineering enhanced protein disaggregases for neurodegenerative disease.
Jackrel ME; Shorter J
Prion; 2015; 9(2):90-109. PubMed ID: 25738979
[TBL] [Abstract][Full Text] [Related]
18. Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.
Béland M; Roucou X
Prion; 2014; 8(1):106-10. PubMed ID: 24335160
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
Tenreiro S; Munder MC; Alberti S; Outeiro TF
J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
[TBL] [Abstract][Full Text] [Related]
20. Fundamentals of prion diseases and their involvement in the loss of function of cellular prion protein.
Sakudo A; Ikuta K
Protein Pept Lett; 2009; 16(3):217-29. PubMed ID: 19275734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
